Literature DB >> 19224310

An epidemiological study of neuromyelitis optica in Cuba.

Jose A Cabrera-Gómez1, John F Kurtzke, Alina González-Quevedo, R Lara-Rodríguez.   

Abstract

INTRODUCTION: Two population-based studies of neuromyelitis optica (NMO) in non-white populations provided prevalence rates of 0.32 and 3.1 per 100,000 population.
OBJECTIVE: To estimate NMO prevalence in the multiethnic Cuban population by nation-wide case ascertainment.
METHODS: The study was conducted from October 1, 2003 to November 30, 2004. Ninety percent of general practitioners and all neurologists responded positively to the request for information on cases suspected of optic neuritis (ON), transverse myelitis (TM), multiple sclerosis, or NMO. Among the population of 11,177,743 there were 798 suspected cases, including 89 with possible NMO, relapsing ON (RON) and TM. Of the 89, 87 were examined by two of us (Cabrera JA, Lara R) who selected the NMO cases according to the 1999 Mayo Clinic criteria as well as those with relapsing TM and RON.
RESULTS: 58 cases provided a prevalence rate of 0.52 per 100,000 (95% CI 0.39-0.67). The 7 males and 51 females gave rates of 0.13 (CI 0.05-0.26) and 0.91 (CI 0.68-1.20). The estimated average annual incidence rate was 0.053 per 100,000 (CI 0.040-0.068). Prevalence rates did not differ significantly among the three ethnic groups. Black NMO cases were significantly older, with more relapses and motor deficit, as well as more abnormalities in brainstem evoked potentials and in brain MRI (not meeting MS criteria). The predominant clinical form was relapsing over monophasic.
CONCLUSIONS: This Cuban multiethnic population had a prevalence of NMO of 0.52 per 100,000 and an estimated average annual incidence rate of 0.053 per 100,000 with no differences by ethnicity. Black patients were older, with more relapses and motor impairment.

Entities:  

Mesh:

Year:  2009        PMID: 19224310     DOI: 10.1007/s00415-009-0009-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  37 in total

1.  MS and neuromyelitis optica in Martinique (French West Indies).

Authors:  P Cabre; O Heinzlef; H Merle; G G Buisson; O Bera; R Bellance; J C Vernant; D Smadja
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  [NEUROMYELITIS OPTICA: PRESENTATION OF A CASE WITH ANATOMOPATHOLOGIC STUDY].

Authors:  J BORGESITURRIZA; J E GONZALEZALFONZO; B VONSCHILLING; H WANIS; M SILVACORDOBA
Journal:  Gac Med Caracas       Date:  1963 Jan-Dec

3.  Neuromyelitis optica (Devic's disease).

Authors:  M A Khan; P S Mahar; V U Raghuraman
Journal:  Br J Clin Pract       Date:  1990-12

4.  Epidural anaesthesia for Caesarean section in a patient with Devic's Syndrome.

Authors:  B Gunaydin; D Akcali; M Alkan
Journal:  Anaesthesia       Date:  2001-06       Impact factor: 6.955

5.  Multiple sclerosis: report on 200 cases from Curitiba, Southern Brazil and comparison with other Brazilian series.

Authors:  W O Arruda; R H Scola; H A Teive; L C Werneck
Journal:  Arq Neuropsiquiatr       Date:  2001-06       Impact factor: 1.420

6.  Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients.

Authors:  Albert Saiz; Luigi Zuliani; Yolanda Blanco; Bruno Tavolato; Bruno Giometto; Francesc Graus
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

7.  [Devic's optic neuromyelitis: presentation as an inflammatory spinal tumour].

Authors:  G Echevarría; G Tróccolli; E D'Annuncio; O Gutiérrez
Journal:  Rev Neurol       Date:  2001 Jul 1-15       Impact factor: 0.870

8.  Down's syndrome and neuromyelitis optica (Devic's disease). An autopsy-proven case.

Authors:  J A Cabrera-Gómez; J Galarraga-Inza; R M Coro-Antich; Y Real-González; M Cristofol-Corominas; H Gómez; K Romero-Garcia; M X Gil-Gil; A Gonzalez-Quevedo
Journal:  Mult Scler       Date:  2007-04       Impact factor: 6.312

9.  Brain abnormalities in neuromyelitis optica.

Authors:  Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2006-03

10.  Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

Authors:  R N Mandler; L E Davis; D R Jeffery; M Kornfeld
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

View more
  45 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Neuromyelitis optica - an update: 2007-2009.

Authors:  Anu Jacob
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

3.  Racial differences in neuromyelitis optica spectrum disorder.

Authors:  Su-Hyun Kim; Maureen A Mealy; Michael Levy; Felix Schmidt; Klemens Ruprecht; Friedemann Paul; Marius Ringelstein; Orhan Aktas; Hans-Peter Hartung; Nasrin Asgari; Jessica Li Tsz-Ching; Sasitorn Siritho; Naraporn Prayoonwiwat; Hyun-June Shin; Jae-Won Hyun; Mira Han; Maria Isabel Leite; Jacqueline Palace; Ho Jin Kim
Journal:  Neurology       Date:  2018-10-26       Impact factor: 9.910

4.  Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation.

Authors:  Sabrina Gmuca; Duriel I Hardy; Sona Narula; Sharon Stoll; Julia Harris; Yongdong Zhao; Rui Xiao; Pamela F Weiss; Amy T Waldman; Jeffrey S Gerber
Journal:  Mult Scler Relat Disord       Date:  2019-11-01       Impact factor: 4.339

Review 5.  Longitudinally extensive myelopathy in children.

Authors:  Danielle Eckart Sorte; Andrea Poretti; Scott D Newsome; Eugen Boltshauser; Thierry A G M Huisman; Izlem Izbudak
Journal:  Pediatr Radiol       Date:  2015-01-31

6.  Intractable nausea and vomiting from autoantibodies against a brain water channel.

Authors:  Raffaele Iorio; Claudia F Lucchinetti; Vanda A Lennon; Gianrico Farrugia; Pankaj J Pasricha; Brian G Weinshenker; Sean J Pittock
Journal:  Clin Gastroenterol Hepatol       Date:  2012-12-01       Impact factor: 11.382

7.  Neuromyelitis Optica Spectrum Disorder in a Chinese Woman with Ocular Myasthenia Gravis: First Reported Case in the Chinese Population.

Authors:  Gordon S K Yau; Jacky W Y Lee; Theo T K Chan; Can Y F Yuen
Journal:  Neuroophthalmology       Date:  2014-04-02

8.  Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta.

Authors:  Sara Salama; Hazem Marouf; M Ihab Reda; Amal R Mansour; Osama ELKholy; Michael Levy
Journal:  J Neuroimmunol       Date:  2018-08-29       Impact factor: 3.478

Review 9.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Authors:  Marios C Papadopoulos; Jeffrey L Bennett; Alan S Verkman
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

Review 10.  Advances in multiple sclerosis research in 2009.

Authors:  Stefan Nessler; Wolfgang Brück
Journal:  J Neurol       Date:  2010-08-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.